Clinical Trial

Efficacy of a Novel Myopia Defocus Spectacle Lens in School-Aged Children

Study acronym: BLMC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the short-term efficacy and safety of a novel, proprietary spectacle lens. Forty myopic participants, aged 6 to 15 years, will be prescribed with the study spectacles for a period of six months. All subjects will be required to attend five scheduled visits. Change in subfoveal choroidal thickness (SfChT), axial length and refraction will be determined.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-04
notable Enrollment increased: 40 -> 50 participants 2026-06-04
critical Recruitment opened 2026-04-21
Trial Details
NCT Number NCT07511387
Lead Sponsor The Hong Kong Polytechnic University
Collaborators: Bausch & Lomb Incorporated
Conditions Myopia
Enrollment 50 participants
Start Date 2026-04-10
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-03